Bristol-Myers Squibb Co (LTS:0R1F) Earnings per Share (Diluted)

: $3.86 (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

Bristol-Myers Squibb Co's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was $0.87. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $3.86.

Bristol-Myers Squibb Co's EPS (Basic) for the three months ended in Dec. 2023 was $0.87. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $3.88.

Bristol-Myers Squibb Co's EPS without NRI for the three months ended in Dec. 2023 was $1.70. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $7.50.

During the past 12 months, Bristol-Myers Squibb Co's average EPS without NRIGrowth Rate was -2.50% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 5.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 14.80% per year. During the past 10 years, the average EPS without NRI Growth Rate was 18.70% per year.

During the past 13 years, Bristol-Myers Squibb Co's highest 3-Year average EPS without NRI Growth Rate was 36.10% per year. The lowest was -20.90% per year. And the median was 9.95% per year.

Bristol-Myers Squibb Co Earnings per Share (Diluted) Historical Data

The historical data trend for Bristol-Myers Squibb Co's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Earnings per Share (Diluted)

Get a 7-Day Free Trial

2.01

-3.99

3.12

2.95

3.86

Bristol-Myers Squibb Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Earnings per Share (Diluted)	Get a 7-Day Free Trial															0.95	1.07	0.99	0.93	0.87

Competitive Comparison

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bristol-Myers Squibb Co PE Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's PE Ratio falls into.

Bristol-Myers Squibb Co Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Bristol-Myers Squibb Co's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(8025	-	0)	/	2078.000
	=	3.86

Bristol-Myers Squibb Co's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends	/	Shares Outstanding (Diluted Average)
	=	(1762	-	0)	/	2033.000
	=	0.87

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.86

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.

Bristol-Myers Squibb Co (LTS:0R1F) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Bristol-Myers Squibb Co Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co (LTS:0R1F) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (LTS:0R1F) » Definitions » Earnings per Share (Diluted)

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina

Address

430 East 29th Street, 14th Floor, New York, NY, USA, 10016

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

Bristol-Myers Squibb Co (LTS:0R1F) Headlines

No Headlines